February 28, 2025
Eisai Delivers New Data and Highlights Continued Progress of Oncology Portfolio and Pipeline at ASCO 2023

TOKYO, May 24, 2023 – (JCN Newswire) – Eisai Co., Ltd. announced today the presentation of research across various types of cancer from its oncology portfolio and pipeline during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO23), which is taking place virtually and in-person in Chicago…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *